The Benefits of FTE Contracts for Pharmaceutical Companies
How can an FTE-based partnership with a CRO transform your pharmaceutical development?
Batch Release Testing and QP Certification: The Backbone of Pharmaceutical Quality Assurance
Are strict pharmaceutical regulations slowing your EU market entry? You’re not alone. Navigating the complex landscape of batch release testing can be challenging, particularly for pharmaceutical manufacturers outside the EU.
Conscio Group Appoints Gary Chambers as Executive Vice President of Strategy and Marketing
April 3, 2025 – Conscio Group, a leading scientific service provider for the pharmaceutical industry, announces the appointment of Gary Chambers as Executive Vice President (EVP) of Strategy and Marketing.
Expediting Biosimilar development: Streamlining the path from research to market
A free webinar on the future of biosimilar pathway to approval is now available for registration
Conscio Group and Kiel Laboratories Announce Strategic Partnership
Conscio Group, a European network of GMP/GLP/GCP/IEC-certified contract R&D service providers, and Kiel Laboratories, Inc., a leading U.S. pharmaceutical research and development company, today announced a strategic partnership to enhance drug development capabilities and market access for their respective clients.
Meet us at the heart of Pharma at CPHI 2024
Conscio Group is attending CPHI 2024 in Milan, Italy.
A new partnership with Reference Analytics GmbH
The Conscio Group is expanding its range of services in Austria by acquiring Reference
Analytics GmbH.
Our new clinical unit in Ostrava (CZ) comes to life
It’s a great pleasure to announce that after two years of hard work, the brand-new clinical unit in Ostrava (CZ) with 36-beds capacity has been opened.
Microbiology and Batch Testing: Bridging Across Sectors
Discover LVA GmbH and EL Labs s.r.o., the only Conscio Group subsidiaries at the intersection of our Pharma and Nutrition end-to-end solutions.
Ekolab and Conscio Group join forces
Ekolab joins the Conscio Group, enhancing our analytical capabilities and solidifying our position in pharmaceutical, nutrition, and technology solutions.